(Q34554073)

English

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

darbepoetin alfa

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Toru Sugiyama

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Noriyuki Katsumata

6

object named as

Noriyuki Katsumata

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Yasuo Ohashi

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yukari Uemura

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yasuhito Fujisaka

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hironobu Ohmatsu

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Rumiko Okamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Nagahiro Saijo

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tomomitsu Hotta

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

15 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

481-485

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

The erythropoietin receptor in normal and cancer tissues

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12105

21 January 2018

Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23331490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23331490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer trial with erythropoietin terminated unexpectedly

1 reference

https://pubmed.ncbi.nlm.nih.gov/23331490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23331490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CAS.12105

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34554073&oldid=1822356941"